Broadbridge VT - Search Results

1

Cetuximab in metastatic colorectal cancer.

Broadbridge VT, Karapetis CS, Price TJ. Broadbridge VT, et al. Expert Rev Anticancer Ther. 2012 May;12(5):555-65. doi: 10.1586/era.12.25. Expert Rev Anticancer Ther. 2012. PMID: 22594891 Review.

2

Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia.

Hocking C, Broadbridge VT, Karapetis C, Beeke C, Padbury R, Maddern GJ, Roder DM, Price TJ. Hocking C, et al. Among authors: broadbridge vt. Med J Aust. 2014 Oct 20;201(8):462-6. doi: 10.5694/mja14.00046. Med J Aust. 2014. PMID: 25332033

3

Rechallenge with oxaliplatin and fluoropyrimidine for metastatic colorectal carcinoma after prior therapy.

Townsend AR, Bishnoi S, Broadbridge V, Beeke C, Karapetis CS, Jain K, Luke C, Padbury R, Price TJ. Townsend AR, et al. Am J Clin Oncol. 2013 Feb;36(1):49-52. doi: 10.1097/COC.0b013e31823fe40e. Am J Clin Oncol. 2013. PMID: 22270106

4

Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence.

Tapia Rico G, Townsend AR, Broadbridge V, Price TJ. Tapia Rico G, et al. Drugs Aging. 2017 Mar;34(3):173-189. doi: 10.1007/s40266-017-0439-9. Drugs Aging. 2017. PMID: 28197947 Review.

5

Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?

Broadbridge VT, Karapetis CS, Beeke C, Woodman RJ, Padbury R, Maddern G, Kim SW, Roder D, Hakendorf P, Price TJ. Broadbridge VT, et al. Br J Cancer. 2013 Sep 3;109(5):1338-43. doi: 10.1038/bjc.2013.388. Epub 2013 Jul 16. Br J Cancer. 2013. PMID: 23860523 Free PMC article.

6

Can we accurately report PTEN status in advanced colorectal cancer?

Hocking C, Hardingham JE, Broadbridge V, Wrin J, Townsend AR, Tebbutt N, Cooper J, Ruszkiewicz A, Lee C, Price TJ. Hocking C, et al. BMC Cancer. 2014 Feb 25;14:128. doi: 10.1186/1471-2407-14-128. BMC Cancer. 2014. PMID: 24564252 Free PMC article. Clinical Trial.

7

Targeting Mutated KRAS Genes to Treat Solid Tumours.

Krishnan T, Roberts-Thomson R, Broadbridge V, Price T. Krishnan T, et al. Mol Diagn Ther. 2022 Jan;26(1):39-49. doi: 10.1007/s40291-021-00564-0. Epub 2021 Dec 16. Mol Diagn Ther. 2022. PMID: 34914038 Review.

8

Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study.

Dean A, Gill S, McGregor M, Broadbridge V, Järveläinen HA, Price T. Dean A, et al. Lancet Gastroenterol Hepatol. 2022 Oct;7(10):943-951. doi: 10.1016/S2468-1253(22)00167-4. Epub 2022 Jul 6. Lancet Gastroenterol Hepatol. 2022. PMID: 35803294 Clinical Trial.

9

Reversing Hyperammonemia in Neuroendocrine Tumors.

Broadbridge V, Townsend A, Pittman K, Kimber R, Patterson W, Sukumaran S, Price TJ. Broadbridge V, et al. J Clin Gastroenterol. 2010 Sep;44(8):e186-9. doi: 10.1097/MCG.0b013e3181d96aad. J Clin Gastroenterol. 2010. PMID: 20453660

10

A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.

Vatandoust S, Joshi R, Pittman KB, Esterman A, Broadbridge V, Adams J, Singhal N, Yeend S, Price TJ. Vatandoust S, et al. Support Care Cancer. 2014 Feb;22(2):513-8. doi: 10.1007/s00520-013-2004-3. Support Care Cancer. 2014. PMID: 24122404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page